中文
NAMIC
Nucleic Acid Medicine Innovation Center (NAMIC)

Nucleic Acid Medicine Innovation Center (NAMIC)

        

The NAMIC under Haichang Biotech is dedicated to the research and development of innovative nucleic acid therapeutics. NAMIC aims to expand the applications of QTsome™, our proprietary lipid nanoparticle (LNP) delivery technology, across various nucleic acid therapeutics, and to cultivate a world-class platform for mRNA therapeutic delivery systems.

In our pursuit of a comprehensive strategy to mRNA therapy, NAMIC hones in on the design, synthesis, optimization, and delivery of nucleic acid therapeutics. This allows us to leverage the entire product lifecycle, from upstream to downstream processes. Innovation forms the core of NAMIC, and we are committed to creating a globally connected network that encapsulates complementary advantages, seamless integration, and adherence to internationally-recognized standards.

NAMIC consists of:

        Division of mRNA Drug Substance Research (DMDSR)

        Division of mRNA Drug Product Research (DMDPR)

        Division of Small RNA Research (DSRR)

        Division of Product Formulation Research (DPFR)

        Division of Pharmaceutics Analysis (DPA) 

        

We are a hub of brilliant minds. At NAMIC, we have gathered outstanding talents around the world to drive research. This global vision and focus on top-notch mind have helped us to become a leading research institute, frequently achieving technical breakthroughs in nucleic acid drug development.

As we navigate the ever-evolving world of biomedical research, NAMIC remains devoted to expanding its global presence. Our continuous efforts are to deliver top-quality health products for everyone, everywhere.

Technology Platform of Nucleic Acid Medicine Innovation Center
  • Synthetic Biology Platform

    Synthetic Biology
     

    Design, synthesis, modification, and optimization of nucleic acid sequences

    01

    Synthetic Biology Platform

    Synthetic Biology
     

    Design, synthesis, modification, and optimization of nucleic acid sequences

    01
  • Characteristic Materials Delivery

    Characteristic Materials Delivery

    Synthesis, modification, and optimization of lipid components

    02

    Characteristic Materials Delivery

    Characteristic Materials Delivery

    Synthesis, modification, and optimization of lipid components

    02
  • Acid Delivery System Platform

    Nucleic Acid Delivery System
     

    Optimization and upgrading of QTsomeTM

    03

    Acid Delivery System Platform

    Nucleic Acid Delivery System

    Optimization and upgrading of QTsomeTM

    03
  • Commercial Production

    Commercial Production
     

    Transformation and commercial production of nucleic acid drugs

    04

    Commercial Production

    Commercial Production
     

    Transformation and commercial production of nucleic acid drugs

    04
Research Area of NAMIC

01 mRNA vaccine for infectious diseases

COVID-19 vaccine
Influenza vaccine
Rabies vaccine
RSV vaccine

02 mRNA vaccine for tumors

Individualized tumor vaccine
Intratumoral immunotherapy

03 mRNA drug for rare diseases

Glycogen storage disease of propionic acidemia (PA)

04Small nucleic acid drug

ASO
siRNA
miRNA
Aptamer

05Research on nucleic acid delivery system

Research Area of NAMIC
+86-571-26262022